相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanobody-mediated resistance to Grapevine fanleaf virus in plants
Caroline Hemmer et al.
PLANT BIOTECHNOLOGY JOURNAL (2018)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities
Sam Massa et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2016)
Type VI secretion and anti-host effectors
Abderrahman Hachani et al.
CURRENT OPINION IN MICROBIOLOGY (2016)
Nanobodies as therapeutics: big opportunities for small antibodies
Sophie Steeland et al.
DRUG DISCOVERY TODAY (2016)
Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis
Qian Zhong et al.
MOLECULAR PHARMACEUTICS (2016)
Nanoparticle-dendrimer hybrid nanocapsules for therapeutic delivery
Youngdo Jeong et al.
NANOMEDICINE (2016)
Crossing the barrier: treatment of brain tumors using nanochain particles
Efstathios Karathanasis et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2016)
Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization
Marta M. Kijanka et al.
EJNMMI RESEARCH (2016)
Identification of protein secretion systems in bacterial genomes
Sophie S. Abby et al.
SCIENTIFIC REPORTS (2016)
Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting
Sander A. A. Kooijmans et al.
JOURNAL OF EXTRACELLULAR VESICLES (2016)
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies
Ema Romao et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine
Sang-Soo Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Natural liposomes and synthetic polymeric structures for biomedical applications
Laura K. Mueller et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells
Camille Levy et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome
Cleo Goyvaerts et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Nanoparticle therapeutics: Technologies and methods for overcoming cancer
Brenda Brenner S. Cerqueira et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Liposomes as nanomedical devices
Giuseppina Bozzuto et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
A bacterial type III secretion-based protein delivery tool for broad applications in cell biology
Simon J. Ittig et al.
JOURNAL OF CELL BIOLOGY (2015)
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
Maarten Van Roy et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives
ChristianaM. Neophytou et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines
Cleo Goyvaerts et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Intelligent nanoparticles for advanced drug delivery in cancer treatment
David S. Spencer et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2015)
Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging
Sam Massa et al.
BIOCONJUGATE CHEMISTRY (2014)
A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis
Fatemeh Araste et al.
BIOTECHNOLOGY LETTERS (2014)
Molecular Imaging with Macrophage CRIg-Targeting Nanobodies for Early and Preclinical Diagnosis in a Mouse Model of Rheumatoid Arthritis
Fang Zheng et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Progress of engineered antibody-targeted molecular imaging for solid tumors (Review)
Hong Zhao et al.
Molecular Medicine Reports (2014)
Methods for site-specific drug conjugation to antibodies
Christopher R. Behrens et al.
MABS (2014)
Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies
K. Zarschler et al.
NANOSCALE (2014)
Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity
Koen Wagner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeted Radionuclide Therapy with A 177Lu-labeled Anti-HER2 Nanobody
Matthias D'Huyvetter et al.
THERANOSTICS (2014)
Nanobody: The Magic Bullet for Molecular Imaging?
Rubel Chakravarty et al.
THERANOSTICS (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain
Ji-yun Huang et al.
BIOMATERIALS (2013)
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
Marina Talelli et al.
BIOMATERIALS (2013)
Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery
Marta Kijanka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
Stephanie D. Steichen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Monoclonal antibodies in oncology therapeutics: present and future indications
Divaya Bhutani et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Isil Altintas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Targeting tumors with nanobodies for cancer imaging and therapy
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2013)
SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis
StePhanie Put et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Targeting of Human Antigen-Presenting Cell Subsets
Cleo Goyvaerts et al.
JOURNAL OF VIROLOGY (2013)
Inhibition of Tumor Growth by Targeted Anti-EGFR/IGF-1R Nanobullets Depends on Efficient Blocking of Cell Survival Pathways
Roy van der Meel et al.
MOLECULAR PHARMACEUTICS (2013)
Nanobody-Functionalized Polymersomes for Tumor-Vessel Targeting
Marjoke F. Debets et al.
MACROMOLECULAR BIOSCIENCE (2013)
Nanobodies and their potential applications
Gholamreza Hassanzadeh-Ghassabeh et al.
NANOMEDICINE (2013)
Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth
Mahdi Behdani et al.
NEW BIOTECHNOLOGY (2013)
In Vivo Neutralization of α-Cobratoxin with High-Affinity Llama Single-Domain Antibodies (VHHs) and a VHH-Fc Antibody
Gabrielle Richard et al.
PLOS ONE (2013)
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Karl R. Schmitz et al.
STRUCTURE (2013)
Immune modulation by genetic modification of dendritic cells with lentiviral vectors
Therese Liechtenstein et al.
VIRUS RESEARCH (2013)
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
Filip Callewaert et al.
BLOOD (2012)
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
Alexis Broisat et al.
CIRCULATION RESEARCH (2012)
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2012)
Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators
Matthias D'Huyvetter et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2012)
Targeting epidermal growth factor receptor in tumors: From conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies
Isil Altintas et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells
C. Goyvaerts et al.
GENE THERAPY (2012)
Albumin-based nanoparticles as potential controlled release drug delivery systems
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Polymeric micelles drug delivery system in oncology
Jian Gong et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanobody-coupled microbubbles as novel molecular tracer
Sophie Hernot et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment
Roy van der Meel et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes
Alyona Sukhanova et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
T Cell Receptor-Like Recognition of Tumor In Vivo by Synthetic Antibody Fragment
Keith R. Miller et al.
PLOS ONE (2012)
Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects
Jeroen A. J. M. van de Water et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The TITAN trial - Assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura
Josefin-Beate Holz
TRANSFUSION AND APHERESIS SCIENCE (2012)
Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-infrared Fluorescent Anti-Epidermal Growth Factor Receptor Nanobody
Sabrina Oliveira et al.
MOLECULAR IMAGING (2012)
Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
Lea Olive Tchouate Gainkam et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2011)
DARPins and other repeat protein scaffolds: advances in engineering and applications
Ykelien L. Boersma et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
Ilse Vaneycken et al.
FASEB JOURNAL (2011)
Lentiviral Vectors: Their Molecular Design, Safety, and Use in Laboratory and Preclinical Research
Boro Dropulic
HUMAN GENE THERAPY (2011)
Antibody-targeted nanoparticles for cancer therapy
Francois Fay et al.
IMMUNOTHERAPY (2011)
A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
Rob C. Roovers et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Nanobody - Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting
Marina Talelli et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Correlation Between Epidermal Growth Factor Receptor-Specific Nanobody Uptake and Tumor Burden: A Tool for Noninvasive Monitoring of Tumor Response to Therapy
Lea Olive Tchouate Gainkam et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Nanoparticle PEGylation for imaging and therapy
Jesse V. Jokerst et al.
NANOMEDICINE (2011)
Optical Imaging in Cancer Research: Basic Principles, Tumor Detection, and Therapeutic Monitoring
Metasebya Solomon et al.
MEDICAL PRINCIPLES AND PRACTICE (2011)
Polymer nanoparticles: Preparation techniques and size-control parameters
J. Prasad Rao et al.
PROGRESS IN POLYMER SCIENCE (2011)
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
David Escors et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
Marina Talelli et al.
BIOMATERIALS (2010)
Differential tumor-targeting abilities of three single-domain antibody formats
Andrea Bell et al.
CANCER LETTERS (2010)
Antibody-drug conjugates: targeted drug delivery for cancer
Stephen C. Alley et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Near-infrared fluorescence: application to in vivo molecular imaging
Scott A. Hilderbrand et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy
Jacek Capala et al.
CURRENT OPINION IN ONCOLOGY (2010)
Targeted core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
M. Talelli et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Downregulation of EGFR by a novel multivalent nanobody-liposome platform
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2010)
A Novel Promiscuous Class of Camelid Single-Domain Antibody Contributes to the Antigen-Binding Repertoire
Nick Deschacht et al.
JOURNAL OF IMMUNOLOGY (2010)
Direct Injection of Functional Single-Domain Antibodies from E. coli into Human Cells
Ana Blanco-Toribio et al.
PLOS ONE (2010)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer
Eyal Mishani et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Michael M. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Janusz Wesolowski et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Strategies for Targeting Lentiviral Vectors
Cecilia Frecha et al.
CURRENT GENE THERAPY (2008)
DARPins: A new generation of protein therapeutics
Michael T. Stumpp et al.
DRUG DISCOVERY TODAY (2008)
Monoclonal antibodies in cancer therapy: 25 years of progress
Robert K. Oldham et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT
Lea Olive Tchouate Gainkam et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
Bernard M. Tijink et al.
MOLECULAR CANCER THERAPEUTICS (2008)
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression
Lieven Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Nanoparticles for drug delivery in cancer treatment
Barbara Haley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Conditional inactivation of HIF-1 using intrabodies
Arjan J. Groot et al.
CELLULAR ONCOLOGY (2008)
Functional antibodies produced by oncolytic clostridia
Arjan J. Groot et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Properties, production, and applications of camelid single-domain antibody fragments
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α
Yang Lu et al.
MOLECULAR CANCER (2007)
Engineering targeted viral vectors for gene therapy
Reinhard Waehler et al.
NATURE REVIEWS GENETICS (2007)
Production and characterization of anti-(mucin MUCI) single-domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi)
Ahmad Ismaili et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Synthetic affibody molecules: A novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors
Anna Orlova et al.
CANCER RESEARCH (2007)
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
J. Theys et al.
BRITISH JOURNAL OF CANCER (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells
Christoph Mamot et al.
JOURNAL OF DRUG TARGETING (2006)
Clostridium spores as anti-tumour agents
L Van Mellaert et al.
TRENDS IN MICROBIOLOGY (2006)
Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha
AJ Groot et al.
LABORATORY INVESTIGATION (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo
C Mamot et al.
CANCER RESEARCH (2005)
Prokaryotic expression of antibodies
M Arbabi-Ghahroudi et al.
CANCER AND METASTASIS REVIEWS (2005)
Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen
E Dolk et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Nanostructure-mediated drug delivery
Gareth A. Hughes
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2005)
Nanobodies as novel agents for cancer therapy
H Revets et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Efficient cancer therapy with a nanobody-based conjugate
V Cortez-Retamozo et al.
CANCER RESEARCH (2004)
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents
LH Dang et al.
CANCER BIOLOGY & THERAPY (2004)
Steric stabilization of core-shell nanoparticles in liquid carbon dioxide at the vapor pressure
JL Dickson et al.
LANGMUIR (2004)
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
C Bettegowda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Emergence and evolution of functional heavy-chain antibodies in Camelidae
KE Conrath et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2003)
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging
V Ntziachristos et al.
EUROPEAN RADIOLOGY (2003)
Microbubble ultrasound contrast agents: a review
E Stride et al.
PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE (2003)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
Efficient tumor targeting by single-domain antibody fragments of camels
V Cortez-Retamozo et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis
SC Liu et al.
GENE THERAPY (2002)
Combination bacteriolytic therapy for the treatment of experimental tumors
LH Dang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Isolation of antigen specific Llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae
LGJ Frenken et al.
JOURNAL OF BIOTECHNOLOGY (2000)
Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire
VK Nguyen et al.
EMBO JOURNAL (2000)
分享论文
